Market revenue in 2023 | USD 2,308.2 million |
Market revenue in 2030 | USD 6,121.6 million |
Growth rate | 15% (CAGR from 2023 to 2030) |
Largest segment | Injectables |
Fastest growing segment | Injectables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Injectables, Skin Rejuvenation |
Key market players worldwide | Hologic Inc, AbbVie Inc, Galderma Group AG Registered Shares, Alma Lasers Ltd, UltraShape Ltd. (Syneron Medical), Johnson & Johnson, Merz Pharma, Lumenis, Bausch Health Companies Inc, Cutera Inc, Revance Therapeutics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-invasive aesthetic treatment market will help companies and investors design strategic landscapes.
Injectables was the largest segment with a revenue share of 62.88% in 2023. Horizon Databook has segmented the UK non-invasive aesthetic treatment market based on injectables, skin rejuvenation covering the revenue growth of each sub-segment from 2018 to 2030.
The aesthetic surgery market in the UK is currently valued at approximately USD 4.3 billion, and treatments, such as Botox & dermal fillers, account for nine out of 10 procedures and are valued at about USD 3.3 billion. However, the overall cosmetic market in the country is highly unregulated.
In January 2019, the British Association of Dermatologist agreed to make regulations for dermal fillers more stringent so that malpractices or complications can be avoided. Social media and celebrities have proven to be strong influencers for people to opt for aesthetic procedures.
With increase in advancements in nonsurgical procedures, more people are opting for minimally invasive cosmetic procedures. Minimally invasive procedures are quick, simple, and affordable, with lower risk and minimal or no scarring.
Horizon Databook provides a detailed overview of country-level data and insights on the UK non-invasive aesthetic treatment market , including forecasts for subscribers. This country databook contains high-level insights into UK non-invasive aesthetic treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account